Hormone Replacement Therapy for Women — Benefits, Risks, and What to Expect

Few topics in women's health have been as misunderstood, feared, and debated as hormone replacement therapy. For decades, women were told HRT was dangerous. Then the research was re-examined, the original study's limitations were acknowledged, and the medical community's position shifted dramatically.

Here's where the evidence actually stands — and what you should know if you're considering HRT.

What Is Hormone Replacement Therapy?

HRT involves supplementing hormones — primarily estrogen and progesterone — that your body produces less of during perimenopause and menopause. The goal is to relieve symptoms caused by declining hormone levels and, in many cases, to protect long-term health.

The terminology has evolved:

• HRT (Hormone Replacement Therapy): The traditional term
• MHT (Menopausal Hormone Therapy): The preferred medical term now, emphasizing that this is treatment for menopausal symptoms specifically
• BHRT (Bioidentical Hormone Replacement Therapy): Uses hormones that are chemically identical to what your body produces naturally

For this article, I'll use HRT since that's what most patients search for.

The Symptoms HRT Addresses

Declining estrogen and progesterone can produce a wide range of symptoms. Some are obvious, others are subtler:

Vasomotor symptoms:

• Hot flashes
• Night sweats
• Sleep disruption from temperature fluctuations

Genitourinary symptoms:

• Vaginal dryness and atrophy
• Painful intercourse
• Recurrent urinary tract infections
• Urinary urgency

Neurological and mood:

• Brain fog and difficulty concentrating
• Mood swings, irritability, anxiety
• Depression (new onset or worsening)
• Memory difficulties

Musculoskeletal:

• Joint pain and stiffness
• Accelerated bone loss
• Muscle weakness

Metabolic:

• Weight gain, particularly around the midsection
• Insulin resistance
• Unfavorable changes in cholesterol

HRT is the most effective treatment for vasomotor symptoms. Nothing else comes close. And for many women, addressing these symptoms has a cascading positive effect on sleep, mood, cognitive function, and overall quality of life.

The WHI Study — What Actually Happened

In 2002, the Women's Health Initiative (WHI) trial made headlines that scared an entire generation of women away from HRT. The study reported increased risks of breast cancer, heart disease, and stroke in women taking HRT.

What the headlines didn't say:

• The study population's average age was 63 — many women were starting HRT 10+ years after menopause, which is not how HRT is typically used clinically
• The increased breast cancer risk was small (8 additional cases per 10,000 women per year) and was seen only with combined estrogen-progesterone therapy, not estrogen alone
• Women taking estrogen alone actually had a decreased risk of breast cancer
• The absolute risks were small, but they were reported as relative risks, which made them sound much larger than they were
• Subsequent reanalysis showed that women who started HRT closer to menopause (within 10 years) had significantly different — and often beneficial — outcomes

The medical community spent 20 years correcting the damage from those headlines. Current guidelines from the North American Menopause Society (NAMS), the Endocrine Society, and the American College of Obstetricians and Gynecologists (ACOG) all support HRT for symptomatic women who start within 10 years of menopause or before age 60.

Benefits Beyond Symptom Relief

When initiated at the appropriate time (the "window of opportunity" — within 10 years of menopause onset or before age 60), HRT provides several evidence-based benefits:

Bone protection: Estrogen is the most effective intervention for preventing postmenopausal bone loss. HRT reduces fracture risk at the hip, spine, and other sites.

Cardiovascular protection: When started early, estrogen appears to be cardioprotective. The WHI reanalysis and subsequent studies show reduced coronary artery calcification and lower cardiovascular mortality in women who start HRT in their 50s.

Cognitive benefits: Emerging evidence suggests that early HRT may be protective against cognitive decline and Alzheimer's disease, though this is still being studied.

Metabolic improvements: HRT can improve insulin sensitivity, reduce visceral fat accumulation, and favorably affect cholesterol profiles.

Genitourinary health: Estrogen (local or systemic) reverses vaginal atrophy, reduces UTI frequency, and improves urinary symptoms. Local vaginal estrogen is so effective and low-risk that it can be used even in women who have contraindications to systemic HRT.

Types of HRT

Estrogen:

• Oral (pills): Convenient but undergoes first-pass liver metabolism, which increases clotting factor production
• Transdermal (patches, gels, sprays): Bypasses the liver, lower clotting risk, preferred for women with cardiovascular risk factors or migraine
• Vaginal (creams, rings, tablets): Local treatment for genitourinary symptoms with minimal systemic absorption

Progesterone:

• Required for any woman with a uterus who takes systemic estrogen (to protect the endometrial lining from hyperplasia)
• Micronized progesterone (Prometrium) is the preferred form — better safety profile and fewer side effects than synthetic progestins
• Not needed if only using local vaginal estrogen

Bioidentical vs. synthetic:

Bioidentical hormones (17-beta estradiol, micronized progesterone) are molecularly identical to what your body produces. They are available as FDA-approved products — you don't need to go to a compounding pharmacy to get them. Compounded bioidentical hormones have a role for customized dosing, but FDA-approved versions should be the starting point.

Testosterone:

Some women benefit from low-dose testosterone for libido, energy, and well-being. This is an off-label use but is supported by growing evidence and endorsed by several international menopause societies.

Risks: The Honest Picture

HRT is not risk-free, and an honest physician will discuss:

Breast cancer: Combined estrogen-progesterone therapy is associated with a small increased risk of breast cancer with prolonged use (beyond 5 years). Estrogen-only therapy (for women without a uterus) has not shown increased breast cancer risk. Using micronized progesterone rather than synthetic progestins may further reduce this risk.

Blood clots: Oral estrogen increases clotting risk. Transdermal estrogen does not appear to carry this risk, making it the preferred route for women with clotting risk factors.

Stroke: A small increased risk has been observed with oral estrogen, particularly in older women. Again, transdermal delivery appears to mitigate this risk.

Gallbladder disease: Oral estrogen increases gallbladder disease risk. Transdermal does not.

The pattern is clear: many of the risks attributed to HRT are specifically related to oral estrogen and synthetic progestins. Using transdermal estradiol and micronized progesterone — which is current best practice — substantially reduces these risks.

Who Should NOT Take HRT

HRT is contraindicated in women with:

• Active or recent breast cancer
• Active liver disease
• Unexplained vaginal bleeding
• Known clotting disorder or active blood clots
• History of stroke or heart attack (case by case)

The CORAL Approach

At CORAL, hormone management for women starts with comprehensive lab work — not a symptom checklist and a generic prescription. Dr. Tae Y. Kim, DO, evaluates:

• Estradiol, progesterone, testosterone, DHEA-S
• Thyroid function (TSH, free T3, free T4)
• Metabolic markers (fasting insulin, glucose, lipid panel)
• Vitamin D, B12, ferritin
• Complete blood count

This lab-based approach ensures that your treatment is targeted, monitored, and adjusted based on objective data — not guesswork.

Frequently Asked Questions

At what age should I consider HRT?

HRT is most beneficial when started during perimenopause or within 10 years of menopause onset. For most women, this means their late 40s to mid-50s. Starting HRT after age 60 or more than 10 years past menopause carries higher risks and requires careful evaluation.

How long can I stay on HRT?

There's no arbitrary time limit. Current guidelines suggest using the lowest effective dose and reassessing periodically. Many women use HRT for 5-10 years or longer, depending on ongoing symptoms, risk factors, and benefit. The decision to continue should be individualized.

Will HRT help me lose weight?

HRT can improve body composition — reducing visceral fat and improving insulin sensitivity — but it's not a weight loss treatment. Women who combine HRT with proper nutrition and exercise often see improved results compared to those relying on lifestyle alone.

Is bioidentical HRT safer than traditional HRT?

Bioidentical hormones (17-beta estradiol and micronized progesterone) do appear to have a more favorable safety profile than older synthetic formulations, particularly regarding clotting and breast cancer risk. However, "bioidentical" is not a magic word — proper dosing, monitoring, and physician oversight are still essential.

Can I get HRT through telehealth?

Yes. CORAL offers telehealth consultations for hormone management across Florida. Lab work can be completed at a local facility, and your physician reviews results and creates your treatment plan via video visit.

---

If you're experiencing symptoms of hormonal change and want answers — not guesses — CORAL provides lab-based, physician-monitored hormone therapy tailored to your needs. [Start your consultation](/start) to take the first step.